We’re pleased to keep our customers and future customers up to date with both company and industry news.
Here you will find all our latest news and company announcements along with our thoughts on what’s happening in the world of medical device manufacturing.
Strategic supplier partnership with Europlaz Technologies Ltd underpins continuity of supply and Ori’s readiness to serve cell therapy programs at all stages, worldwide.LONDON, UK, and Southminster UK November 11, 2026 – Oribiotech Ltd. (Ori), a leader in advanced...
Let’s talk about your prototype If you're moving from 3D printed or prototype parts towards clinical trials or manufacture, an early conversation could help you identify potential issues before they affect your timescale. Book a free, no-obligation 30-minute prototype...
The life sciences sector encompasses a broad and diverse range of products, technologies and manufacturing requirements. Across human medicines, medical diagnostics, MedTech products, biologics, vaccines, cell therapies and gene therapies, organisations are working to...
Supporting life science organisations from technology transfer to commercial manufacture Whether you're an emerging innovator preparing for your first manufacturing transfer or an established global organisation looking for a trusted manufacturing partner, Europlaz...
Europlaz is proud to announce that we have been named a finalist in the Lloyds British Business Excellence Awards 2026, having been shortlisted for The Vistage Growth Business of the Year Award. The company is one of just 11 businesses selected as finalists in the...
At Europlaz, maintaining the highest standards of quality, compliance and customer service is fundamental to everything we do. As part of our commitment to continuous improvement and supporting the future needs of our customers, we are transitioning our certification...
Supporting every stage of drug delivery device commercialisation Drug delivery devices play a critical role in the success of modern therapies. Whether delivering medication via injection, inhalation, sublingual administration, infusion or precision dosing systems,...
By Alastair Fry, Head of Regulatory Affairs at Europlaz When people talk about medical device development, the focus often lands on functionality, usability and clinical performance. Those things matter, of course. But from a regulatory and patient safety perspective,...
Early manufacturing input can help design houses and OEM engineering teams avoid costly issues later in development. In medical device development, small decisions made early can have a big impact later. A tolerance that looks acceptable on paper may create assembly...
By Katy O’Keeffe, Director, Europlaz Manufacturing has spent years telling itself the same story: there aren’t enough skilled people. Teams are ageing, fewer young people are entering engineering, and businesses are struggling to recruit. After more than twenty years...
Capabilities, compliance requirements & supplier selection framework Choosing between UK contract medical device manufacturers (CM) is one of the most consequential decisions in bringing a device from design to market. The right partner reduces regulatory risk,...
Strengthening digital capability through Government-supported investment Europlaz is delighted to announce the successful completion of a significant digital transformation project made possible through the Made Smarter Adoption East of England Programme. The...
